Company news
Abingdon Health PLC news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Completion of Technical Transfer & initial orders
April 5, 2022
Strategic collaboration with Vatic Health Limited
March 29, 2022
Strategic collaboration with DeepVerge plc
March 29, 2022
Trading and Strategic Update
March 2, 2022
UK Government study gives insight on SARS-CoV-2
March 2, 2022
Update on AffiDX® SARS-CoV-2 antigen LFT
January 10, 2022
Results of General Meeting and Open Offer
December 20, 2021
CE-marking and commercial launch of Semi-Q Test
December 16, 2021
Publication of Annual Report and Notice of AGM
December 3, 2021
Open Offer Launch, Posting of Circular, GM Notice
December 2, 2021
Result of Placing, PrimaryBid and Subscription
December 1, 2021
Close of Accelerated Bookbuild & PrimaryBid Offer
December 1, 2021
PrimaryBid Offer
December 1, 2021
Proposed Fundraising
December 1, 2021
Launch of Semi-Quantitative Accessory to AbC-19T
September 7, 2021
Launch of BioSURE COVID-19 IgG Antibody Self Test
August 23, 2021
Disclosure of Detailed Grounds for Resistance
August 9, 2021
Publication of an article regarding AbC-19
July 27, 2021
Exclusive Manufacturing Agreement with BioSure
July 23, 2021
Peer reviewed study involving AbC 19
July 9, 2021
Manufacturing Agreement with Bioporto A/S
July 5, 2021
Grant of Options under SAYE Scheme
April 23, 2021
Abingdon Health Notes Announcement by UK-RTC on...
April 19, 2021
Director Dealing
April 6, 2021
AbC-19™ Rapid Test used in UK BioBank COV...
March 29, 2021
Webinar: The role of antibody testing as a comp...
March 10, 2021
Data on AbC-19 as CDx for Pfizer-BioNTech Vaccine
February 24, 2021
Notice of Interim Results
February 23, 2021
Abingdon Health Notes Announcement by UK-RTC
February 16, 2021
Collaboration with Abcam
February 9, 2021
Statement re Media Article
February 8, 2021
Media Clarification
January 27, 2021
Appointment of Chief Financial Officer
January 26, 2021
AbC-19TM Rapid Test Update
December 29, 2020
Admission to trading on AIM & first day dealings
December 15, 2020
Calls
The 5 newest of 7 calls. Every call is listed under its year.
- Abingdon Health (LSE:ABDX) Q4 2026 Earnings Call
Oct 13, 2026
Transcript - Abingdon Health (LSE:ABDX) — Final results for the year ended 30 June 2026
Oct 13, 2026
Transcript - Abingdon Health (LSE:ABDX) — Interim Results
Mar 17, 2026
Transcript - Abingdon Health (LSE:ABDX) — Preliminary results for the year ended 30 June 2025
Nov 11, 2025
Transcript - Abingdon Health (LSE:ABDX) — Interim results for the six months ended 31 December 2024
Mar 26, 2025
Transcript
Decks
- ShareSoc Manchester (May 2026)
Conference · 18 slides · May 12, 2026
- H1 FY26 Earnings Presentation
Earnings · 19 slides · Mar 17, 2026
- FY2024 Earnings Presentation
Earnings · 13 slides · October 2024
- FY2023 Earnings Presentation
Earnings · 11 slides · October 2023